2-232336580-A-G

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong

The NM_152383.5(DIS3L2):ā€‹c.2608A>Gā€‹(p.Lys870Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000603 in 1,608,770 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.000092 ( 0 hom., cov: 33)
Exomes š‘“: 0.000057 ( 1 hom. )

Consequence

DIS3L2
NM_152383.5 missense

Scores

19

Clinical Significance

Uncertain significance criteria provided, multiple submitters, no conflicts U:5

Conservation

PhyloP100: -0.101
Variant links:
Genes affected
DIS3L2 (HGNC:28648): (DIS3 like 3'-5' exoribonuclease 2) The protein encoded by this gene is similar in sequence to 3'/5' exonucleolytic subunits of the RNA exosome. The exosome is a large multimeric ribonucleotide complex responsible for degrading various RNA substrates. Several transcript variants, some protein-coding and some not, have been found for this gene. [provided by RefSeq, Mar 2012]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.021950454).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
DIS3L2NM_152383.5 linkuse as main transcriptc.2608A>G p.Lys870Glu missense_variant 21/21 ENST00000325385.12 NP_689596.4
DIS3L2NM_001257281.2 linkuse as main transcriptc.1582-6765A>G intron_variant NP_001244210.1
DIS3L2NR_046476.2 linkuse as main transcriptn.2681A>G non_coding_transcript_exon_variant 21/21
DIS3L2NR_046477.2 linkuse as main transcriptn.3254A>G non_coding_transcript_exon_variant 19/19

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
DIS3L2ENST00000325385.12 linkuse as main transcriptc.2608A>G p.Lys870Glu missense_variant 21/215 NM_152383.5 ENSP00000315569 P1Q8IYB7-1

Frequencies

GnomAD3 genomes
AF:
0.0000922
AC:
14
AN:
151912
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000484
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000583
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.000478
GnomAD3 exomes
AF:
0.000115
AC:
28
AN:
243444
Hom.:
0
AF XY:
0.000150
AC XY:
20
AN XY:
133172
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000335
Gnomad SAS exome
AF:
0.0000981
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000134
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000570
AC:
83
AN:
1456858
Hom.:
1
Cov.:
31
AF XY:
0.0000717
AC XY:
52
AN XY:
724954
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.0000895
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000202
Gnomad4 SAS exome
AF:
0.000151
Gnomad4 FIN exome
AF:
0.0000206
Gnomad4 NFE exome
AF:
0.0000477
Gnomad4 OTH exome
AF:
0.0000663
GnomAD4 genome
AF:
0.0000922
AC:
14
AN:
151912
Hom.:
0
Cov.:
33
AF XY:
0.0000674
AC XY:
5
AN XY:
74212
show subpopulations
Gnomad4 AFR
AF:
0.0000484
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000583
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000118
Gnomad4 OTH
AF:
0.000478
Alfa
AF:
0.0000849
Hom.:
0
Bravo
AF:
0.0000680
ExAC
AF:
0.000124
AC:
15
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Perlman syndrome Uncertain:2
Uncertain significance, criteria provided, single submitterclinical testingFulgent Genetics, Fulgent GeneticsOct 31, 2018- -
Uncertain significance, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 02, 2024This sequence change replaces lysine, which is basic and polar, with glutamic acid, which is acidic and polar, at codon 870 of the DIS3L2 protein (p.Lys870Glu). This variant is present in population databases (rs775252407, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with DIS3L2-related conditions. ClinVar contains an entry for this variant (Variation ID: 463111). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
not specified Uncertain:1
Uncertain significance, no assertion criteria providedclinical testingGenetic Services Laboratory, University of ChicagoDec 15, 2022DNA sequence analysis of the DIS3L2 gene demonstrated a sequence change, c.2608A>G, in exon 21 that results in an amino acid change, p.Lys870Glu. This sequence change does not appear to have been previously described in individuals with DIS3L2-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.012% in the overall population (dbSNP rs775252407). The p.Lys870Glu change affects a poorly conserved amino acid residue located in a domain of the DIS3L2 protein that is not known to be functional. The p.Lys870Glu substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). Due to insufficient evidences and the lack of functional studies, the clinical significance of the p.Lys870Glu change remains unknown at this time. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 28, 2022The c.2608A>G (p.K870E) alteration is located in exon 21 (coding exon 20) of the DIS3L2 gene. This alteration results from a A to G substitution at nucleotide position 2608, causing the lysine (K) at amino acid position 870 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
not provided Uncertain:1
Uncertain significance, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.064
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
2.3
DANN
Benign
0.31
DEOGEN2
Benign
0.0033
T;T
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.00043
N
LIST_S2
Benign
0.20
T;.
M_CAP
Benign
0.00093
T
MetaRNN
Benign
0.022
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.20
N;N
MutationTaster
Benign
1.0
N;N;N
PrimateAI
Benign
0.30
T
PROVEAN
Benign
-0.30
N;N
REVEL
Benign
0.040
Sift
Benign
1.0
T;T
Sift4G
Benign
0.48
T;T
Polyphen
0.0
B;B
Vest4
0.24
MutPred
0.27
Loss of ubiquitination at K870 (P = 0.0051);Loss of ubiquitination at K870 (P = 0.0051);
MVP
0.14
MPC
0.30
ClinPred
0.0063
T
GERP RS
0.34
Varity_R
0.044
gMVP
0.11

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs775252407; hg19: chr2-233201290; API